The Traderszone Network

Published in TZ Latest News 15 July, 2015 by The TZ Newswire Staff

Why Shares in PTC Therapeutics, Inc. Are Soaring 10% Higher Today

Investor optimism for PTC Therapeutics is climbing ahead of confirmatory phase 3 results that could advance a U.S. filing for approval.